- This event has passed.
Monoclonals and More: Issues and Opportunities with Early COVID-19 Treatment Options
November 12, 2021 @ 12:30 pm - 2:00 pm
In the Updated COVID-19 Treatment Guidelines on Prioritization of Anti-SARS-CoV-2 Monoclonal Antibodies for the Treatment or Prevention of SARS-CoV-2 Infection when there are Logistical or Supply Constraints, the COVID-19 Treatment Guidelines Panel recommends the use of anti-SARS-CoV-2 monoclonal antibodies (mAbs) for individuals who are at high risk for progression to severe COVID-19.
Presenters on this webinar will review some of the most current recommendations for use of mAbs and upcoming therapies and the challenges and opportunities that they may pose in conjunction with mAb and other treatments (e.g., prioritization and distribution). Speakers will also highlight operational principles for a scaled strategy for use of these therapeutics in a scarce resource situation. The webinar will take place on Friday, November 12, 2021, from 12:30-2:00 PM ET.
SPEAKERS
Introductions: Shayne Brannman, MS, Director, ASPR TRACIE Moderator: John Hick, MD, Hennepin Healthcare
Panelists:
- Jay Epstein, MD, Medical Officer, COVID-19 Therapeutics Program, Office of the Assistant Secretary for Preparedness and Response, HHS
- Rajesh Gandhi, MD, Professor of Medicine, Harvard Medical School; Director of HIV Clinical Services and Education, Massachusetts General Hospital; Co-Director of the Harvard University Center for AIDS Research (CFAR); and Member, NIH Covid-19 Treatment Guidelines Panel and the Infectious Diseases Society of America (IDSA) Covid-19 Treatment Guidelines Panel
- Dan Hanfling, MD, Co-Chair, National Academy of Medicine Forum on Medical/Public Health Preparedness
- Anne Zink, MD, FACEP, Chief Medical Officer, Alaska Department of Health & Social Services, Division of Public Health; President-Elect, ASTHO
REGISTRATION
REGISTER HERE for this free webinar; it will also be recorded and archived on the ASPR TRACIE website. Each registrant will receive a unique link needed to access the webinar. Please note: The link can only be used on one computer; registrants should not forward their registration confirmation emails to others.
Audio: You can use your computer microphone and speakers (VoIP) or telephone. A phone number and PIN will be provided after logging into the webinar.